ADVOCACY

  • Gearing Up for JDRF’s 2013 Children’s Congress!

    This summer, approximately 160 children and teenagers from throughout the U.S., and several from around the world, will converge in Washington, D.C., from July 8-10 for the JDRF 2013 Children’s Congress, the largest grassroots advocacy event focused on type 1 diabetes (T1D).  Read our News Release

    Children’s Congress

  • The 2012 JDRF Annual Report is out.

    This past year’s annual report examines our 42-year history, including exciting developments from the last year. We invite you to explore this year’s report here – which is now delivered in a fresh, online format.

    Read the interactive report.

    The 2012 JDRF Annual Report

  • Congress Renews the SDP

    As one of its final acts of the 112th Congress, the Congress has renewed the Special Diabetes Program, fully funded at $150 Million, for one year.

    SDP research continues to ensure we cure, treat & prevent type 1 diabetes.

    Learn More

    Congress Renews the SDP
FOLLOW US
FacebookTwitterYouTubePinterestJuvenation Blog

The SDP Impact

Explore Stories from people who benefit from SDP.
See All
  • Read more

    Nilia had no family history of type 1 diabetes (T1D), but newborn screening, as part of a Special Diabetes Program (SDP) funded trial, found she is at risk for developing it.

    — NiliaSDP Trial Participant

    Read More

    Nilia had no family history of type 1 diabetes (T1D), but newborn screening, as part of a Special Diabetes Program (SDP) funded trial, found she is at risk for developing it.  She is participating in the trial until age 15 or T1D onset to help determine if diet, illnesses, or other exposures during her childhood are environmental triggers of T1D onset.  This critically important research could enable scientists to prevent T1D altogether.  Helping others along the way – SDP-related research underway today will not only continue to help prevent or delay the onset of complications in more than 26 million Americans with diabetes, it could also improve the lives of people living with autoimmune and other diseases.
  • Read more

    Kerry experienced the thrill of not having to worry about her diabetes for a few days when she participated in an artificial pancreas trial.

    — KerryArtificial Pancreas Trial Participant

    Read More

    Diagnosed with T1D at age 4, Kerry experienced the thrill of not having to worry about her diabetes for a few days when she participated in an artificial pancreas trial.  The artificial pancreas, which automatically controls blood sugar levels, has been tested in a hospital setting with great results.  The next step is further testing in patients at home so the technology can one day be available to all people with T1D.  The development of this technology would be the biggest breakthrough since the discovery of insulin.
  • Read more

    After having T1D for over 25 years, Kathy would experience sudden low blood sugars without warning.

    — KathyIslet Cell Transplant Participant

    Read More

    After having T1D for over 25 years, Kathy would experience sudden low blood sugars without warning.  She had an islet cell transplant in 2008 and today she only takes a small supplemental dose of insulin each day.  She feels wonderful and no longer worries about sudden lows as she feels them well before they hit.  Her blood sugars are in very good control – closer to those of a person who doesn’t have T1D.
See All Impact Stories

What do you like about the SDP?

Explore the benefits and share them with friends.
Learn More

  • Prevention/Cure

    SDP Research – The Path to Prevention and a Cure

    SDP directly advances the fight to cure, treat and prevent T1D.
    Due to the SDP, scientists are making rapid strides in understanding the multiple causes of T1D, opening up exciting new avenues to cure, treat and prevent T1D.

  • Improving Lives

    SDP improves the lives of millions diagnosed with diabetes

    The SDP has led to new insights and therapies that have improved the lives of people with diabetes.
    Sustaining a commitment to SDP will be measured in saved and improved lives for 26 million people living with diabetes.

  • Innovation

    SDP leads to innovative, life-changing therapies.

    The artificial pancreas will help diabetes patients better manage blood sugar levels.
    SDP funded research has accelerated the development of artificial pancreas systems which will help diabetes patients better manage blood sugar levels and reduce complications.

  • Cost Savings

    SDP will help reduce staggering cost of diabetes

    Making an investment in the SDP now will result in significant cost savings down the road.
    Sustaining a commitment to SDP will be measured in reduced health care costs in the private sector and government entitlement programs.
Learn more about the SDP

Stay Connected with the Issues that matter to T1D advocates.

Letter from the Grassroots Leader
From Camille Nash
I am honored and excited to serve as JDRF's National Volunteer Advocacy Leader. My role is to partner with you to ensure that our legislators support funding for research and technology to improve the lives of those with Type 1 diabetes through better therapies and ultimately a cure.
Continue ReadingWrite Your Own Letter